Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity

NCT01327976 is registered in ClinicalTrials.gov with ReShape Lifesciences as lead sponsor.

NCT NCT01327976
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01327976 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity
Lead sponsor
ReShape Lifesciences
Phase
Not applicable
Overall status
Unknown status
Start date
May 31, 2011
Completion date
January 31, 2021
Enrollment
239 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

obesity